Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Generalized and specific whole-brain white matter abnormalities in human cocaine and heroin use disorders

View ORCID ProfilePierre-Olivier Gaudreault, Sarah King, Pias Malaker, Nelly Alia-Klein, Rita Z. Goldstein
doi: https://doi.org/10.1101/2022.03.22.22272765
Pierre-Olivier Gaudreault
Psychiatry and Neuroscience Departments, Icahn School of Medicine at Mount Sinai, New York City, NY, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pierre-Olivier Gaudreault
Sarah King
Psychiatry and Neuroscience Departments, Icahn School of Medicine at Mount Sinai, New York City, NY, USA
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pias Malaker
Psychiatry and Neuroscience Departments, Icahn School of Medicine at Mount Sinai, New York City, NY, USA
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nelly Alia-Klein
Psychiatry and Neuroscience Departments, Icahn School of Medicine at Mount Sinai, New York City, NY, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rita Z. Goldstein
Psychiatry and Neuroscience Departments, Icahn School of Medicine at Mount Sinai, New York City, NY, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rita.goldstein{at}mssm.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Neuroimaging studies in substance use disorder have shown widespread impairments in white matter (WM) microstructure suggesting demyelination and axonal damage. However, substantially fewer studies explored generalized vs. acute/specific drug effects on WM. Our study assessed whole-brain WM integrity in three subgroups of addicted individuals, encompassing cocaine (CUD) and heroin (HUD) use disorder, compared to healthy controls (CTL).

Diffusion MRI was acquired in 58 CTL, 28 current cocaine users/CUD+, 32 abstinent cocaine users/CUD−, and 30 individuals with HUD (positive urine for cocaine in CUD+ and opiates used for treatment in HUD). Tract-Based Spatial Statistics allowed voxelwise analyses of diffusion metrics [fractional anisotropy/FA, mean diffusivity/MD, radial diffusivity/RD, and axial diffusivity/AD]. Permutation statistics (p-corrected<.05) were used for between-group t-tests.

Compared to CTL, all drug-addicted individuals showed widespread FA reductions, and increased MD, RD, and AD (19-57% of WM skeleton, p<.05). The HUD showed the most impairments, followed by the CUD+, with only minor FA reductions in CUD− (<.2% of skeleton, p=.05). Longer periods of regular use were associated with decreased FA and AD, and higher subjective craving was associated with increased MD, RD, and AD, across all drug-addicted individuals (p<.05).

These findings demonstrate extensive WM impairments in drug-addicted individuals characterized by decreased anisotropy and increased diffusivity, thought to reflect demyelination and lower axonal packing. Extensive abnormalities in both groups with positive urine status (CUD+ and HUD), and correlations with craving, suggest greater WM impairments with recency of use. Results in CUD−, and correlations with regular use, further imply cumulative and/or persistent WM damage.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the National Institute on Drug Abuse (Goldstein, 1R01DA048301-01A1), the National Center for Complementary and Integrative Health (Goldstein, 1R01AT010627-01), and the Canadian Institutes of Health Research (Gaudreault, postdoctoral research fellowship).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All participants provided written informed consent and study procedures were approved by the Icahn School of Medicine at Mount Sinai institutional review board.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted March 22, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Generalized and specific whole-brain white matter abnormalities in human cocaine and heroin use disorders
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Generalized and specific whole-brain white matter abnormalities in human cocaine and heroin use disorders
Pierre-Olivier Gaudreault, Sarah King, Pias Malaker, Nelly Alia-Klein, Rita Z. Goldstein
medRxiv 2022.03.22.22272765; doi: https://doi.org/10.1101/2022.03.22.22272765
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Generalized and specific whole-brain white matter abnormalities in human cocaine and heroin use disorders
Pierre-Olivier Gaudreault, Sarah King, Pias Malaker, Nelly Alia-Klein, Rita Z. Goldstein
medRxiv 2022.03.22.22272765; doi: https://doi.org/10.1101/2022.03.22.22272765

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Addiction Medicine
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3294)
  • Dentistry and Oral Medicine (364)
  • Dermatology (279)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13376)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5153)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3268)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (431)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14628)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (523)
  • Neurology (4925)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (724)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4212)
  • Public and Global Health (7504)
  • Radiology and Imaging (1705)
  • Rehabilitation Medicine and Physical Therapy (1013)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)